Last Price
3.56
Today's Change
+0.21 (6.26%)
Day's Change
3.31 - 3.79
Trading Volume
2,796,839
Market Cap
382 Million
Shares Outstanding
107 Million
Avg Volume
1,573,171
Avg Price (50 Days)
7.09
Avg Price (200 Days)
8.66
PE Ratio
-3.10
EPS
-1.15
Earnings Announcement
17-Mar-2025
Previous Close
3.35
Open
3.37
Day's Range
3.31 - 3.795
Year Range
2.7 - 13.005
Trading Volume
2,796,839
1 Day Change
6.27%
5 Day Change
22.76%
1 Month Change
-48.10%
3 Month Change
-60.66%
6 Month Change
-51.30%
Ytd Change
-64.33%
1 Year Change
-52.97%
3 Year Change
-73.63%
5 Year Change
-65.20%
10 Year Change
-65.20%
Max Change
-65.20%
No result.
Sector: Healthcare - Healthcare
Industry: Biotechnology
Description:
Tango Therapeutics, Inc., a biotechnology company, discovers and develops drugs for the treatment of cancer. Its lead program is TNG908, a synthetic lethal small molecule inhibitor of protein arginine methyltransferase 5 that is being developed as a treatment for cancers with methylthioadenosine phosphorylase deletions. The company also develops Ubiquitin-specific protease 1, an inhibitor to treat patients with BRCA1 or BRCA2-mutant cancers; and Target 3 for STK11-mutant cancers. Tango Therapeutics, Inc. has a strategic collaboration with Gilead Sciences, Inc. for the discovery, development, and commercialization of a pipeline of therapies for patients with cancer. The company was founded in 2017 and is based in Cambridge, Massachusetts.